SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES). This is an ASCO Meeting ...

Reducing Daunorubicin in Induction Therapy in Children With B-Lineage ALL With Favorable Prognosis: Results of Phase III Trial AIEOP-BFM ALL 2009 We analyzed clinical and molecular features from ...

Actuate Therapeutics, Inc. has announced the completion of the Phase 1 study evaluating its drug elraglusib in pediatric patients with refractory malignancies, specifically Ewing Sarcoma (EWS). The ...

In our three-part series -- Fighting For Hope: Pediatric Cancer's Funding Crisis -- 3News' Maureen Kyle follows the journey of young patients and their families as they navigate pediatric cancer. This ...

CLEVELAND — Childhood cancer is the No. 1 disease-related cause of death among children in the United States, with one in six young patients not surviving. For families grappling with a cancer ...

Small blue round cells of Ewing Sarcoma. Nat Pernick, CC BY 3.0, via Wikimedia Commons Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. A ...

Ewing sarcoma is a tumor of the bones and soft tissues that occurs in children and young people. Like all childhood cancers, it is rare – 9 to 10 cases per million inhabitants per year – but it is ...

Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...

HOUSTON, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...